Navigation Links
U.S. Navy Awards Entegrion Contracts for $4 Million for the Development of Critical Blood Products
Date:8/6/2009

The U.S. Navy has awarded two additional contracts to the RTP, NC-based life sciences company Entegrion, Inc., for implementation of the company's proprietary technologies to improve the safety and availability of blood-derived products for treating combat injuries. Recent medical research has demonstrated that such blood component therapy is essential in responding to traumatic injury, especially on the battlefield. The base contracts total about $4 million, with an additional $2 million for expanded research.

Research Triangle Park, NC (PRWEB) August 7, 2009 -- The U.S. Navy has awarded two additional contracts to the life sciences company Entegrion, Inc., for implementation of the company's proprietary technologies to improve the safety and availability of blood-derived products for treating combat injuries. Recent medical research has demonstrated that such blood component therapy is essential in responding to traumatic injury, especially on the battlefield. The base contracts total about $4 million, with an additional $2 million for expanded research.

"Our military does a heroic job in overcoming the logistical challenges of ensuring that critically needed blood supplies are available when and where they are needed," said Joseph DaCorta, Entegrion's Chief Technology Officer. "Trends in clinical practice are moving toward earlier and more aggressive use of blood components after serious injury. However, availability of such therapies is often seriously restricted by shelf-life limitations and storage requirements. Technologies like ours to produce blood-derived products that can be stored for longer periods, do not require refrigeration, and have fewer pathogens will support both military and civilian medical operations by ensuring both the safety and timely availability of blood products to treat serious injuries, particularly in remote and austere areas."

The first of the new contracts is for advanced development of Entegrion's Stasix®, a dehydrated platelet-derived hemostatic agent that can be reconstituted and transfused when needed for the control of non-compressible internal bleeding. The second contract is for advanced development of Entegrion's product, Resusix®, a dehydrated, pathogen-reduced, fresh human plasma for infusion in trauma patients to expand blood volume, correct abnormal coagulation function, and support hemostasis.

"We are honored to have been chosen by the Navy to assist them in meeting these critical requirements. For Entegrion, this represents the fourth major contract for such work over the last six years. We remain totally committed to building on our track record of providing timely and effective R&D to deliver these much needed therapeutics to both our military and the civilian markets that will follow," said Stan Eskridge, Chief Executive Officer of Entegrion.

About Entegrion:
Entegrion is a life sciences company that selectively integrates synergistic technologies with those in its patent portfolio for development of novel devices and drugs for hemorrhage control, resuscitation, and associated tissue repair. The company is based in North Carolina's Research Triangle Park (RTP) and is the inventor of Stasilon®, an FDA-approved medical device technology that is in the form of a textile and is uniquely both hemostatic and non-adherent. Building on technologies licensed from the University of North Carolina, Entegrion's portfolio includes platelet-derived platform technologies that are being developed as topical gels and sprays for tissue repair, infusible hemostatic agents for the control of internal hemorrhage, and novel vehicles for delivery of drugs to targeted tumors and other sites of internal bleeding. For more information, visit www.entegrion.com.

# # #

Read the full story at http://www.prweb.com/releases/blood_research/plasma_platelets/prweb2721004.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MORE (Media Orthopaedic Reporting Excellence) Awards Call for Entries is Now Open
2. Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009
3. Regence Wins Awards for Consumer Appeal to Transform Health Care
4. CDC Recognizes Innovative Obesity Prevention and Control Initiatives With Weight of the Nation Awards
5. Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year
6. Eleven Veterinary Students Win Top Awards at Morris Animal Foundations Annual Research Competition
7. Itanium Solutions Alliance Selects Swedens Kiwok as the 2009 Innovation Awards Winner for Humanitarian Impact
8. Allsup Awards Grant to National Alliance on Mental Illness
9. Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations
10. Lung Cancer Alliance Announces First Request For Bids for Department of Defense Lung Cancer Research Program Concept Awards
11. Jury Awards Valley Medical Center Patient $1.8 Million for Nursing Negligence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Navy Awards Entegrion Contracts for $4 Million for the Development of Critical Blood Products 
(Date:3/27/2017)... ... ... New patients who want to experience the benefits of dental implants ... by Dr. Manju Kejriwal, with or without a referral. Dr. Kejriwal is a respected ... each dental implant placement. The i-CAT CBCT system captures the shapes of oral structures ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... gain site attention and engagement over the household brands of Top-20 pharma by ... will discuss how partnering with the right outsourcing payments provider can provide the ...
(Date:3/27/2017)... ... March 27, 2017 , ... A study by the founder of the ... Sudeep Roy, MD, was recently published in the American Journal of Cosmetic Surgery. “The ... Buckingham and Roy’s study on the use of Electro Lube during the facelift procedure. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO ... Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle ... Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access to ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S Technologies, the first name ... the Smart System® 20/20. CE Certification builds upon M&S's long-standing commitment to products ... as ANSI, ISO and proven test methods used in the field of Vision ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  A new survey from the ... Competitive Bidding Program (CBP) significantly reduced beneficiary choice and ... of choice forces beneficiaries to switch to unfamiliar or ... AADE,s survey is the latest in ... pointing out the inherent problems with the CBP. Last ...
(Date:3/27/2017)... /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or ... is pleased to announce it has received conditional approval ... TSX Venture Exchange.  Receiving the conditional ... significant achievements for Invictus-MD. Some of which include: ... Laboratories Inc. ("AB Labs"), a Licensed Producer under the ...
(Date:3/27/2017)... , March 27, 2017 ... as the NASDAQ Composite closed the trading session up ... and the S&P 500 was down 0.08%. US markets ... sectors finishing the day in green. Pre-market today, Stock-Callers.com ... Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), ...
Breaking Medicine Technology: